Charles Robertson
Concepts (527)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 44 | 2024 | 724 | 3.520 |
Why?
| | Gastrointestinal Microbiome | 32 | 2026 | 767 | 2.570 |
Why?
| | Bacteria | 32 | 2026 | 766 | 1.720 |
Why?
| | RNA, Ribosomal, 16S | 46 | 2026 | 507 | 1.650 |
Why?
| | Cystic Fibrosis | 13 | 2026 | 1164 | 0.940 |
Why?
| | Otitis Media | 6 | 2025 | 178 | 0.870 |
Why?
| | Intestinal Mucosa | 11 | 2025 | 666 | 0.860 |
Why?
| | Feces | 17 | 2025 | 494 | 0.760 |
Why?
| | Intestines | 9 | 2017 | 351 | 0.710 |
Why?
| | Metagenome | 10 | 2019 | 127 | 0.700 |
Why?
| | Biodiversity | 11 | 2020 | 314 | 0.640 |
Why?
| | Nasopharynx | 5 | 2024 | 72 | 0.640 |
Why?
| | Rhinitis | 6 | 2020 | 159 | 0.620 |
Why?
| | Water Microbiology | 8 | 2018 | 86 | 0.590 |
Why?
| | Sinusitis | 6 | 2020 | 220 | 0.580 |
Why?
| | Paranasal Sinuses | 5 | 2016 | 77 | 0.530 |
Why?
| | Phylogeny | 13 | 2020 | 921 | 0.500 |
Why?
| | Archaea | 2 | 2008 | 62 | 0.490 |
Why?
| | Air Microbiology | 2 | 2015 | 37 | 0.490 |
Why?
| | Colon | 4 | 2025 | 304 | 0.490 |
Why?
| | Arthritis, Experimental | 3 | 2024 | 142 | 0.490 |
Why?
| | Sequence Analysis, DNA | 14 | 2020 | 771 | 0.460 |
Why?
| | Ileum | 4 | 2020 | 112 | 0.460 |
Why?
| | Breast Feeding | 6 | 2025 | 447 | 0.440 |
Why?
| | Bronchoalveolar Lavage Fluid | 5 | 2026 | 641 | 0.440 |
Why?
| | RNA, Bacterial | 8 | 2018 | 182 | 0.410 |
Why?
| | Sputum | 6 | 2026 | 302 | 0.410 |
Why?
| | Oropharynx | 3 | 2026 | 46 | 0.390 |
Why?
| | Database Management Systems | 1 | 2013 | 50 | 0.390 |
Why?
| | Computer Graphics | 1 | 2013 | 41 | 0.390 |
Why?
| | Railroads | 1 | 2013 | 6 | 0.390 |
Why?
| | User-Computer Interface | 1 | 2013 | 164 | 0.360 |
Why?
| | Aerosols | 1 | 2013 | 146 | 0.360 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 101 | 0.350 |
Why?
| | Geologic Sediments | 2 | 2008 | 46 | 0.350 |
Why?
| | Trachea | 4 | 2023 | 253 | 0.340 |
Why?
| | Colitis | 3 | 2025 | 280 | 0.330 |
Why?
| | Infant Nutritional Physiological Phenomena | 3 | 2025 | 159 | 0.320 |
Why?
| | Crohn Disease | 4 | 2020 | 249 | 0.320 |
Why?
| | Fucosyltransferases | 2 | 2022 | 31 | 0.310 |
Why?
| | HIV Infections | 5 | 2025 | 3210 | 0.310 |
Why?
| | Inflammation | 11 | 2025 | 2915 | 0.300 |
Why?
| | Dysbiosis | 5 | 2023 | 184 | 0.300 |
Why?
| | Humans | 82 | 2026 | 145625 | 0.300 |
Why?
| | DNA, Bacterial | 8 | 2021 | 319 | 0.300 |
Why?
| | Lung | 7 | 2021 | 4119 | 0.290 |
Why?
| | Genes, rRNA | 5 | 2015 | 38 | 0.280 |
Why?
| | Male | 55 | 2026 | 73014 | 0.270 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2022 | 265 | 0.270 |
Why?
| | Software | 1 | 2013 | 673 | 0.270 |
Why?
| | Female | 56 | 2026 | 79080 | 0.270 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 190 | 0.260 |
Why?
| | Case-Control Studies | 15 | 2020 | 3633 | 0.260 |
Why?
| | High-Throughput Nucleotide Sequencing | 8 | 2026 | 538 | 0.250 |
Why?
| | Sulfolobus solfataricus | 1 | 2007 | 9 | 0.250 |
Why?
| | Mice | 23 | 2025 | 18266 | 0.250 |
Why?
| | Legionella | 2 | 2017 | 9 | 0.240 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2026 | 11 | 0.240 |
Why?
| | Mycobiome | 1 | 2026 | 8 | 0.240 |
Why?
| | Animals | 32 | 2025 | 38030 | 0.240 |
Why?
| | Water Pollutants, Chemical | 2 | 2020 | 227 | 0.240 |
Why?
| | Capsule Endoscopy | 1 | 2026 | 22 | 0.240 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2835 | 0.230 |
Why?
| | Cryoelectron Microscopy | 1 | 2007 | 180 | 0.230 |
Why?
| | Dietary Supplements | 3 | 2019 | 586 | 0.230 |
Why?
| | HIV-1 | 2 | 2024 | 911 | 0.230 |
Why?
| | Drinking Water | 3 | 2017 | 90 | 0.230 |
Why?
| | Blueberry Plants | 1 | 2025 | 8 | 0.230 |
Why?
| | Fatty Liver | 2 | 2021 | 251 | 0.230 |
Why?
| | Environmental Microbiology | 1 | 2005 | 46 | 0.230 |
Why?
| | Pseudomonas Infections | 3 | 2023 | 229 | 0.230 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 34 | 0.220 |
Why?
| | Fatty Acids, Volatile | 4 | 2019 | 60 | 0.220 |
Why?
| | Adult | 32 | 2026 | 40821 | 0.220 |
Why?
| | Fungi | 1 | 2026 | 120 | 0.220 |
Why?
| | Eosinophilic Esophagitis | 2 | 2022 | 333 | 0.220 |
Why?
| | Drug Resistance | 2 | 2017 | 145 | 0.220 |
Why?
| | Ear, Middle | 5 | 2025 | 78 | 0.220 |
Why?
| | Ecosystem | 2 | 2007 | 483 | 0.210 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 39 | 0.210 |
Why?
| | Colitis, Ulcerative | 2 | 2020 | 142 | 0.210 |
Why?
| | Pentanols | 1 | 2024 | 6 | 0.210 |
Why?
| | Construction Materials | 2 | 2015 | 18 | 0.210 |
Why?
| | Metagenomics | 3 | 2019 | 153 | 0.210 |
Why?
| | Child | 23 | 2026 | 22638 | 0.210 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 187 | 0.210 |
Why?
| | Lyases | 1 | 2024 | 15 | 0.210 |
Why?
| | Bacteremia | 2 | 2018 | 218 | 0.210 |
Why?
| | Th17 Cells | 1 | 2025 | 103 | 0.210 |
Why?
| | Infant Formula | 2 | 2023 | 71 | 0.200 |
Why?
| | Staphylococcus aureus | 4 | 2021 | 458 | 0.200 |
Why?
| | Liver | 3 | 2020 | 1859 | 0.200 |
Why?
| | Adrenal Cortex Hormones | 3 | 2017 | 483 | 0.200 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 104 | 0.200 |
Why?
| | Butyrates | 1 | 2024 | 65 | 0.200 |
Why?
| | Mice, Inbred C57BL | 13 | 2025 | 6021 | 0.200 |
Why?
| | Respiratory Tract Infections | 3 | 2024 | 399 | 0.200 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2017 | 3930 | 0.190 |
Why?
| | Respiratory System | 2 | 2016 | 150 | 0.190 |
Why?
| | Diet, Western | 2 | 2022 | 88 | 0.190 |
Why?
| | Imaging, Three-Dimensional | 1 | 2007 | 578 | 0.190 |
Why?
| | Anti-Asthmatic Agents | 2 | 2017 | 263 | 0.190 |
Why?
| | Premature Birth | 3 | 2017 | 389 | 0.180 |
Why?
| | Alternative Splicing | 1 | 2025 | 249 | 0.180 |
Why?
| | Milk, Human | 3 | 2023 | 176 | 0.180 |
Why?
| | Staphylococcus | 4 | 2017 | 74 | 0.180 |
Why?
| | Bile Acids and Salts | 2 | 2022 | 162 | 0.180 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2018 | 352 | 0.180 |
Why?
| | Hypersensitivity | 1 | 2025 | 253 | 0.180 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.180 |
Why?
| | Cholesteatoma | 1 | 2022 | 10 | 0.180 |
Why?
| | Iron | 2 | 2016 | 359 | 0.180 |
Why?
| | Arthritis, Rheumatoid | 2 | 2023 | 1184 | 0.180 |
Why?
| | Gastrointestinal Tract | 3 | 2015 | 203 | 0.180 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 411 | 0.170 |
Why?
| | Infant | 12 | 2025 | 10093 | 0.170 |
Why?
| | Anti-Bacterial Agents | 8 | 2023 | 1935 | 0.170 |
Why?
| | Haemophilus Infections | 1 | 2022 | 45 | 0.170 |
Why?
| | Diet | 3 | 2025 | 1271 | 0.170 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 198 | 0.170 |
Why?
| | Staphylococcal Infections | 3 | 2015 | 396 | 0.170 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.160 |
Why?
| | Transcriptome | 3 | 2021 | 1066 | 0.160 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.160 |
Why?
| | Adolescent | 19 | 2026 | 22451 | 0.160 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.160 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 227 | 0.160 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2021 | 58 | 0.160 |
Why?
| | Groundwater | 1 | 2020 | 40 | 0.160 |
Why?
| | Perilipin-2 | 2 | 2017 | 41 | 0.160 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.160 |
Why?
| | Nasal Polyps | 1 | 2020 | 59 | 0.160 |
Why?
| | Cross-Sectional Studies | 11 | 2021 | 5875 | 0.160 |
Why?
| | Mucin 5AC | 1 | 2020 | 71 | 0.150 |
Why?
| | Hot Springs | 2 | 2012 | 8 | 0.150 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 15 | 0.150 |
Why?
| | Birth Weight | 2 | 2020 | 521 | 0.150 |
Why?
| | RNA, Ribosomal | 4 | 2013 | 168 | 0.150 |
Why?
| | Respiratory System Agents | 1 | 2020 | 22 | 0.150 |
Why?
| | Inflammation Mediators | 2 | 2020 | 507 | 0.150 |
Why?
| | Biofilms | 3 | 2017 | 288 | 0.150 |
Why?
| | Bacteroides | 1 | 2019 | 20 | 0.150 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.150 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 145 | 0.150 |
Why?
| | Asthma | 3 | 2017 | 1800 | 0.150 |
Why?
| | Polymerase Chain Reaction | 7 | 2017 | 1030 | 0.150 |
Why?
| | Disease Models, Animal | 8 | 2025 | 4565 | 0.140 |
Why?
| | Esomeprazole | 1 | 2018 | 7 | 0.140 |
Why?
| | Vitamin B Complex | 1 | 2019 | 39 | 0.140 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2017 | 427 | 0.140 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 178 | 0.140 |
Why?
| | Chronic Disease | 7 | 2022 | 1824 | 0.140 |
Why?
| | Oxonic Acid | 1 | 2018 | 13 | 0.140 |
Why?
| | Diet, High-Fat | 2 | 2017 | 267 | 0.140 |
Why?
| | Middle Aged | 21 | 2024 | 36359 | 0.140 |
Why?
| | Alphaproteobacteria | 2 | 2016 | 7 | 0.140 |
Why?
| | Biomarkers | 6 | 2025 | 4329 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 46 | 0.140 |
Why?
| | Child, Preschool | 10 | 2026 | 11888 | 0.140 |
Why?
| | Burns | 1 | 2023 | 365 | 0.140 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 17 | 0.140 |
Why?
| | Genetic Predisposition to Disease | 2 | 2025 | 2455 | 0.140 |
Why?
| | Corrosion | 2 | 2015 | 16 | 0.140 |
Why?
| | Body Mass Index | 4 | 2020 | 2446 | 0.140 |
Why?
| | Hydraulic Fracking | 1 | 2018 | 16 | 0.140 |
Why?
| | Vitamin B 12 | 1 | 2019 | 139 | 0.140 |
Why?
| | Chloramines | 2 | 2015 | 14 | 0.140 |
Why?
| | Probiotics | 1 | 2018 | 61 | 0.130 |
Why?
| | Intubation, Intratracheal | 2 | 2017 | 328 | 0.130 |
Why?
| | Spondylarthritis | 1 | 2018 | 50 | 0.130 |
Why?
| | Immunity, Innate | 3 | 2019 | 843 | 0.130 |
Why?
| | Dacryocystorhinostomy | 1 | 2017 | 13 | 0.130 |
Why?
| | Quinolones | 1 | 2020 | 204 | 0.130 |
Why?
| | Aminophenols | 1 | 2020 | 204 | 0.130 |
Why?
| | Sequence Analysis, RNA | 3 | 2020 | 441 | 0.130 |
Why?
| | Infant, Newborn | 8 | 2025 | 6449 | 0.130 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.130 |
Why?
| | Clostridium Infections | 1 | 2018 | 73 | 0.120 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 563 | 0.120 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 307 | 0.120 |
Why?
| | Sepsis | 1 | 2023 | 668 | 0.120 |
Why?
| | Down Syndrome | 1 | 2023 | 529 | 0.120 |
Why?
| | Pharynx | 1 | 2016 | 60 | 0.120 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 364 | 0.120 |
Why?
| | Pedigree | 3 | 2025 | 507 | 0.120 |
Why?
| | Rivers | 1 | 2016 | 62 | 0.120 |
Why?
| | Vitamin E | 1 | 2016 | 123 | 0.120 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 19 | 0.120 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 6 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 69 | 0.110 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2016 | 61 | 0.110 |
Why?
| | Lipid Metabolism | 2 | 2020 | 533 | 0.110 |
Why?
| | Respiration, Artificial | 3 | 2023 | 711 | 0.110 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.110 |
Why?
| | Base Sequence | 3 | 2015 | 2119 | 0.110 |
Why?
| | Cytokines | 3 | 2025 | 2079 | 0.110 |
Why?
| | Young Adult | 11 | 2021 | 14240 | 0.110 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 20 | 0.110 |
Why?
| | Mice, Knockout | 5 | 2025 | 3121 | 0.110 |
Why?
| | Lactobacillus | 3 | 2022 | 28 | 0.110 |
Why?
| | Dietary Fats | 1 | 2017 | 307 | 0.110 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.110 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 60 | 0.110 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 164 | 0.110 |
Why?
| | Nose | 1 | 2015 | 67 | 0.110 |
Why?
| | Biota | 1 | 2015 | 28 | 0.110 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.110 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 38 | 0.110 |
Why?
| | Health Facilities | 1 | 2015 | 85 | 0.110 |
Why?
| | Bronchi | 1 | 2016 | 263 | 0.110 |
Why?
| | Soil Microbiology | 1 | 2015 | 115 | 0.110 |
Why?
| | Household Articles | 1 | 2014 | 27 | 0.110 |
Why?
| | Siblings | 1 | 2015 | 196 | 0.110 |
Why?
| | Humidity | 1 | 2014 | 50 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 247 | 0.110 |
Why?
| | Prospective Studies | 7 | 2022 | 8087 | 0.100 |
Why?
| | Rats | 6 | 2023 | 5574 | 0.100 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 133 | 0.100 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 130 | 0.100 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2014 | 63 | 0.100 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 639 | 0.100 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 29 | 0.100 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 47 | 0.100 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 662 | 0.100 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 48 | 0.100 |
Why?
| | Cecum | 3 | 2020 | 37 | 0.100 |
Why?
| | Parenteral Nutrition | 1 | 2014 | 102 | 0.100 |
Why?
| | Age Factors | 2 | 2019 | 3321 | 0.100 |
Why?
| | DNA, Ribosomal | 2 | 2015 | 83 | 0.100 |
Why?
| | Nasal Cavity | 1 | 2013 | 60 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 992 | 0.100 |
Why?
| | Bacteroidetes | 3 | 2021 | 20 | 0.100 |
Why?
| | Autoantibodies | 2 | 2018 | 1498 | 0.100 |
Why?
| | Cities | 1 | 2013 | 140 | 0.100 |
Why?
| | New York City | 1 | 2013 | 87 | 0.100 |
Why?
| | Computational Biology | 2 | 2019 | 675 | 0.090 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 67 | 0.090 |
Why?
| | Iron, Dietary | 1 | 2013 | 23 | 0.090 |
Why?
| | Saliva | 1 | 2015 | 256 | 0.090 |
Why?
| | Gastric Bypass | 1 | 2014 | 115 | 0.090 |
Why?
| | Membrane Proteins | 2 | 2019 | 1130 | 0.090 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 119 | 0.090 |
Why?
| | Hippocampus | 1 | 2018 | 986 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 870 | 0.090 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2021 | 333 | 0.090 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 232 | 0.090 |
Why?
| | Antioxidants | 1 | 2016 | 544 | 0.090 |
Why?
| | Pediatric Obesity | 1 | 2020 | 635 | 0.090 |
Why?
| | Prednisone | 1 | 2013 | 229 | 0.090 |
Why?
| | Aged | 11 | 2023 | 26251 | 0.090 |
Why?
| | Carbon Dioxide | 1 | 2014 | 228 | 0.090 |
Why?
| | Seawater | 1 | 2012 | 33 | 0.090 |
Why?
| | Bacterial Infections | 1 | 2014 | 246 | 0.090 |
Why?
| | Infant Food | 1 | 2013 | 69 | 0.090 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 234 | 0.090 |
Why?
| | Paneth Cells | 1 | 2012 | 20 | 0.090 |
Why?
| | Xenobiotics | 1 | 2012 | 30 | 0.090 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 253 | 0.090 |
Why?
| | Mexico | 2 | 2012 | 232 | 0.090 |
Why?
| | Pregnancy | 6 | 2025 | 7217 | 0.090 |
Why?
| | Body Fluids | 1 | 2012 | 70 | 0.090 |
Why?
| | Bacterial Translocation | 1 | 2012 | 51 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 143 | 0.090 |
Why?
| | Sequence Analysis | 1 | 2011 | 32 | 0.080 |
Why?
| | Islets of Langerhans | 2 | 2015 | 852 | 0.080 |
Why?
| | Kidney | 1 | 2018 | 1491 | 0.080 |
Why?
| | Autoimmunity | 2 | 2015 | 924 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2014 | 284 | 0.080 |
Why?
| | Esophagus | 1 | 2012 | 260 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2018 | 1169 | 0.080 |
Why?
| | Autism Spectrum Disorder | 1 | 2015 | 404 | 0.080 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 421 | 0.080 |
Why?
| | Genes, Bacterial | 3 | 2018 | 151 | 0.080 |
Why?
| | Phenotype | 5 | 2020 | 3186 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 93 | 0.080 |
Why?
| | Obesity | 2 | 2021 | 3123 | 0.070 |
Why?
| | Genotype | 4 | 2019 | 1866 | 0.070 |
Why?
| | Cholesterol | 2 | 2022 | 410 | 0.070 |
Why?
| | Pacific Ocean | 1 | 2008 | 8 | 0.070 |
Why?
| | RNA, Archaeal | 1 | 2008 | 12 | 0.070 |
Why?
| | Cohort Studies | 5 | 2019 | 6045 | 0.070 |
Why?
| | DNA, Archaeal | 1 | 2008 | 17 | 0.070 |
Why?
| | Indoles | 1 | 2013 | 509 | 0.070 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 157 | 0.070 |
Why?
| | Pseudomonas aeruginosa | 2 | 2023 | 392 | 0.070 |
Why?
| | Weight Loss | 1 | 2014 | 857 | 0.070 |
Why?
| | Exome | 2 | 2020 | 232 | 0.070 |
Why?
| | Smoke | 2 | 2023 | 149 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2623 | 0.070 |
Why?
| | Methane | 2 | 2020 | 45 | 0.070 |
Why?
| | Bacterial Load | 2 | 2021 | 67 | 0.060 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2007 | 47 | 0.060 |
Why?
| | Cryoprotective Agents | 1 | 2007 | 11 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2013 | 798 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 926 | 0.060 |
Why?
| | Models, Statistical | 1 | 2011 | 667 | 0.060 |
Why?
| | Fatty Acids | 2 | 2022 | 460 | 0.060 |
Why?
| | Freezing | 1 | 2007 | 84 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2025 | 2064 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 973 | 0.060 |
Why?
| | Gammaproteobacteria | 2 | 2016 | 13 | 0.060 |
Why?
| | Equipment Contamination | 2 | 2017 | 67 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2010 | 728 | 0.060 |
Why?
| | Disease Susceptibility | 2 | 2020 | 339 | 0.060 |
Why?
| | Genes, Archaeal | 1 | 2005 | 5 | 0.060 |
Why?
| | Cryopreservation | 1 | 2007 | 115 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 192 | 0.060 |
Why?
| | Rats, Inbred Lew | 2 | 2017 | 105 | 0.050 |
Why?
| | Insulin | 1 | 2016 | 2524 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2013 | 1101 | 0.050 |
Why?
| | Body Composition | 2 | 2021 | 686 | 0.050 |
Why?
| | Hexanols | 1 | 2024 | 7 | 0.050 |
Why?
| | Fruit | 1 | 2025 | 144 | 0.050 |
Why?
| | Water Purification | 2 | 2017 | 156 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2591 | 0.050 |
Why?
| | Mice, Inbred DBA | 1 | 2024 | 185 | 0.050 |
Why?
| | Methylamines | 1 | 2024 | 39 | 0.050 |
Why?
| | Disinfection | 2 | 2017 | 131 | 0.050 |
Why?
| | Treatment Outcome | 5 | 2020 | 11744 | 0.050 |
Why?
| | Gestational Age | 2 | 2017 | 989 | 0.050 |
Why?
| | Geography | 2 | 2014 | 186 | 0.050 |
Why?
| | Tobramycin | 1 | 2023 | 63 | 0.050 |
Why?
| | Choline | 1 | 2024 | 134 | 0.050 |
Why?
| | Administration, Oral | 2 | 2019 | 867 | 0.050 |
Why?
| | RNA, Messenger | 3 | 2018 | 2783 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2017 | 1531 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 533 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 121 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 33 | 0.050 |
Why?
| | Colorado | 3 | 2020 | 4588 | 0.050 |
Why?
| | Azithromycin | 1 | 2023 | 101 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 61 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 8351 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 847 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 56 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 45 | 0.050 |
Why?
| | Cotinine | 1 | 2023 | 77 | 0.050 |
Why?
| | Neutrophils | 2 | 2021 | 1132 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 217 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 183 | 0.050 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 9 | 0.040 |
Why?
| | Water | 2 | 2018 | 451 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2023 | 567 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2017 | 1160 | 0.040 |
Why?
| | Neoplasms | 1 | 2018 | 2944 | 0.040 |
Why?
| | Virulence | 1 | 2023 | 287 | 0.040 |
Why?
| | Brain | 1 | 2014 | 2981 | 0.040 |
Why?
| | Gastritis | 1 | 2022 | 117 | 0.040 |
Why?
| | Multigene Family | 2 | 2012 | 209 | 0.040 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 61 | 0.040 |
Why?
| | Enteritis | 1 | 2022 | 105 | 0.040 |
Why?
| | Endoscopy | 2 | 2015 | 316 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 676 | 0.040 |
Why?
| | Collagen | 1 | 2023 | 460 | 0.040 |
Why?
| | Aerobiosis | 1 | 2020 | 18 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2020 | 3005 | 0.040 |
Why?
| | Smoking | 2 | 2020 | 1478 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2097 | 0.040 |
Why?
| | Mice, Inbred NOD | 2 | 2013 | 598 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2013 | 782 | 0.040 |
Why?
| | Oil and Gas Fields | 1 | 2020 | 32 | 0.040 |
Why?
| | Ear, External | 1 | 2020 | 22 | 0.040 |
Why?
| | Hospitals | 2 | 2015 | 730 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 232 | 0.040 |
Why?
| | Eosinophilia | 1 | 2022 | 224 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 97 | 0.040 |
Why?
| | Cell Line | 2 | 2018 | 2809 | 0.040 |
Why?
| | Mouth | 1 | 2020 | 84 | 0.040 |
Why?
| | Bacterial Proteins | 2 | 2018 | 976 | 0.040 |
Why?
| | Carcinogenesis | 1 | 2022 | 226 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 568 | 0.040 |
Why?
| | Sweat | 1 | 2020 | 52 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 112 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 360 | 0.040 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 16 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 144 | 0.040 |
Why?
| | Restraint, Physical | 1 | 2018 | 70 | 0.040 |
Why?
| | Forced Expiratory Volume | 1 | 2020 | 451 | 0.030 |
Why?
| | Cytoprotection | 1 | 2018 | 55 | 0.030 |
Why?
| | COS Cells | 1 | 2018 | 173 | 0.030 |
Why?
| | Collagen Type II | 1 | 2018 | 54 | 0.030 |
Why?
| | HIV Seropositivity | 1 | 2019 | 117 | 0.030 |
Why?
| | Environmental Monitoring | 1 | 2020 | 346 | 0.030 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 111 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 365 | 0.030 |
Why?
| | Risk Factors | 3 | 2017 | 10840 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 2018 | 97 | 0.030 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Bacterial Toxins | 1 | 2018 | 109 | 0.030 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2017 | 74 | 0.030 |
Why?
| | New Orleans | 1 | 2017 | 19 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 167 | 0.030 |
Why?
| | Chorioamnionitis | 1 | 2017 | 50 | 0.030 |
Why?
| | Prognosis | 2 | 2020 | 4331 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 466 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 449 | 0.030 |
Why?
| | Infant, Extremely Premature | 1 | 2017 | 67 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2017 | 193 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1244 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 95 | 0.030 |
Why?
| | Betaproteobacteria | 1 | 2016 | 7 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 175 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 69 | 0.030 |
Why?
| | Water Supply | 1 | 2017 | 90 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 646 | 0.030 |
Why?
| | Critical Illness | 1 | 2023 | 905 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 611 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 29 | 0.030 |
Why?
| | Ohio | 1 | 2016 | 136 | 0.030 |
Why?
| | Bacillus | 1 | 2015 | 17 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 104 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 746 | 0.030 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 373 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 253 | 0.030 |
Why?
| | Antibiosis | 1 | 2015 | 10 | 0.030 |
Why?
| | Streptococcus mitis | 1 | 2015 | 10 | 0.030 |
Why?
| | Catalase | 1 | 2015 | 133 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 6 | 0.030 |
Why?
| | Pre-Eclampsia | 1 | 2017 | 206 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 994 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3917 | 0.030 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 79 | 0.030 |
Why?
| | Rectum | 1 | 2016 | 180 | 0.030 |
Why?
| | Pseudomonas | 1 | 2015 | 30 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 40 | 0.030 |
Why?
| | Kenya | 1 | 2015 | 129 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 503 | 0.030 |
Why?
| | Pennsylvania | 1 | 2015 | 136 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 3 | 0.030 |
Why?
| | Enterobacteriaceae | 1 | 2015 | 44 | 0.030 |
Why?
| | Carrier State | 1 | 2015 | 80 | 0.030 |
Why?
| | DNA | 2 | 2014 | 1418 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 21 | 0.030 |
Why?
| | Proteobacteria | 1 | 2014 | 15 | 0.030 |
Why?
| | Physical Exertion | 1 | 2015 | 204 | 0.030 |
Why?
| | Corynebacterium | 1 | 2015 | 50 | 0.030 |
Why?
| | Plant Oils | 1 | 2014 | 33 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2014 | 90 | 0.030 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 43 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 923 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2014 | 90 | 0.030 |
Why?
| | Kupffer Cells | 1 | 2014 | 52 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 166 | 0.030 |
Why?
| | Spirometry | 1 | 2015 | 234 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 95 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 511 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2018 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 202 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 494 | 0.020 |
Why?
| | Poly I-C | 1 | 2013 | 58 | 0.020 |
Why?
| | Gene Expression | 1 | 2018 | 1461 | 0.020 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 37 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2012 | 2228 | 0.020 |
Why?
| | Cell Separation | 1 | 2014 | 300 | 0.020 |
Why?
| | Observer Variation | 1 | 2014 | 355 | 0.020 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 151 | 0.020 |
Why?
| | Connectome | 1 | 2014 | 99 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 384 | 0.020 |
Why?
| | Nitrates | 1 | 2013 | 97 | 0.020 |
Why?
| | Seasons | 1 | 2015 | 535 | 0.020 |
Why?
| | Perioperative Care | 1 | 2015 | 229 | 0.020 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.020 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.020 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.020 |
Why?
| | Genetic Markers | 1 | 2013 | 337 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 276 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 43 | 0.020 |
Why?
| | DNA, Viral | 1 | 2014 | 352 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 316 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1878 | 0.020 |
Why?
| | Neural Pathways | 1 | 2014 | 318 | 0.020 |
Why?
| | Lubiprostone | 1 | 2012 | 9 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.020 |
Why?
| | Alprostadil | 1 | 2012 | 29 | 0.020 |
Why?
| | Phototrophic Processes | 1 | 2012 | 1 | 0.020 |
Why?
| | Infant, Premature | 1 | 2017 | 622 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1983 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 54 | 0.020 |
Why?
| | Electrolytes | 1 | 2012 | 52 | 0.020 |
Why?
| | Hot Temperature | 1 | 2015 | 396 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 331 | 0.020 |
Why?
| | Chlorine | 1 | 2012 | 59 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 110 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 122 | 0.020 |
Why?
| | Cyanobacteria | 1 | 2012 | 51 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2910 | 0.020 |
Why?
| | Skin | 1 | 2016 | 701 | 0.020 |
Why?
| | Suction | 1 | 2011 | 31 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1367 | 0.020 |
Why?
| | Chloride Channel Agonists | 1 | 2012 | 111 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2015 | 473 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2013 | 543 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 399 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 964 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 239 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 519 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2017 | 1118 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5397 | 0.020 |
Why?
| | Adiposity | 1 | 2015 | 531 | 0.020 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 46 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2013 | 377 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2357 | 0.020 |
Why?
| | Nutritional Status | 1 | 2013 | 344 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2012 | 751 | 0.020 |
Why?
| | Escherichia coli Proteins | 1 | 2012 | 200 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 474 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 537 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2857 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 319 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4112 | 0.020 |
Why?
| | Biopsy | 1 | 2012 | 1073 | 0.020 |
Why?
| | Risk | 1 | 2011 | 917 | 0.020 |
Why?
| | Mutation | 1 | 2020 | 4082 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1790 | 0.020 |
Why?
| | Thermus | 1 | 2007 | 1 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 831 | 0.020 |
Why?
| | Chloroflexi | 1 | 2007 | 12 | 0.020 |
Why?
| | Mining | 1 | 2007 | 36 | 0.020 |
Why?
| | Macrophages | 1 | 2014 | 1530 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1444 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 991 | 0.010 |
Why?
| | Hospitalization | 1 | 2015 | 2468 | 0.010 |
Why?
| | Temperature | 1 | 2007 | 633 | 0.010 |
Why?
| | United States | 1 | 2015 | 16041 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2012 | 17291 | 0.010 |
Why?
|
|
Robertson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|